Biomolecular Life Holdings, Inc. (BIOM)
OTCMKTS · Delayed Price · Currency is USD
0.4700
0.00 (0.00%)
At close: Sep 23, 2026

BIOM Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '14 Dec '13 Dec '12
Selling, General & Admin
0.30.30.263.283.12.1
Research & Development
---0.870.810.5
Operating Expenses
0.30.30.264.143.912.6
Operating Income
-0.3-0.3-0.26-4.14-3.91-2.6
Interest Expense
-0.02-0.02-0.02-2.76-1.08-3.76
Other Non Operating Income (Expenses)
-0.29-0.030.060.68-2.5-0.58
EBT Excluding Unusual Items
-0.61-0.35-0.22-6.22-7.48-6.94
Pretax Income
-0.61-0.35-0.22-6.22-7.48-6.94
Earnings From Continuing Operations
-0.61-0.35-0.22-6.22-7.48-6.94
Minority Interest in Earnings
---0.030.060.09
Net Income
-0.61-0.35-0.22-6.19-7.42-6.85
Net Income to Common
-0.61-0.35-0.22-6.19-7.42-6.85
Net Income Growth
------
Shares Outstanding (Basic)
111---
Shares Outstanding (Diluted)
111---
Shares Change
-0.65%----
EPS (Basic)
-0.57-0.33-0.21---
EPS (Diluted)
-0.57-0.33-0.21---
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '14 Dec '13 Dec '12
Free Cash Flow
-0.06-0.06-0.02-1.91-1.04-0.96
Free Cash Flow Per Share
-0.05-0.05-0.02---
EBIT
-0.3-0.3-0.26-4.14-3.91-2.6